GC Biopharma Financial Statements
We are disclosing financial information
To help investors
Make informed decisions.
※ Corporate bonds are submitted for credit evaluation every year
| Type | Korea Ratings | Credit rating | A+ (in 2022) |
|---|---|---|---|
| NICE Ratings | A+ (in 2023) |
-
- GC MS
- GC Wellbeing
- GCMedis
-
- Overseas
- GC China Pharm
- Curevo
- GC Pharma do Brasil
-
- Foundation
- MOGAM Institue
- GC Labs
- GC i-Med
-
- Others
- GC Invacfarm